Perrigo Company plc Increase (Decrease) in Insurance Settlements Receivable
Perrigo Company plc (PRGO) reported Increase (Decrease) in Insurance Settlements Receivable of -$98.00 million for the 3-month period ending 2025-03-29, per its 10-Q filed 2025-05-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInsuranceSettlementsReceivable · last filed 2026-02-26
- Perrigo Company plc increase (decrease) in insurance settlements receivable for the quarter ending 2025-03-29 was -$98.00M.
- Perrigo Company plc increase (decrease) in insurance settlements receivable for fiscal 2024 was -$98.00M.
| Period end | Increase (Decrease) in Insurance Settlements Receivable 3 month | Increase (Decrease) in Insurance Settlements Receivable 12 month |
|---|---|---|
| 2025-03-29 | -$98.00M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | -$98.00M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |